"St. Luke’s Behavioral Health Center is a 127-bed facility located in the heart of Phoenix, Arizona. The Behavioral Health Center offers a full spectrum of inpatient and outpatient services for seniors, adults, adolescents, and children requiring psychiatric and chemical dependency care. Individualized treatment plans are developed by our certified doctors and trusted physicians through a collaborative effort between each patient and our caring and experienced staff. We maintain a holistic approach to treatment that addresses each person’s physiological, psychological, spiritual, and social needs."

During the past decade, St. Luke's Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Medical Center" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "BridgePoint Medical" with 2 trials sponsored, "Cardiovascular Systems Inc" with 2 trials sponsored, "Chugai Pharma USA" with 1 trials sponsored and "Medtronic Endovascular" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Medical Center" #1 collaborator was "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Medical Center" are "Atherosclerosis" (2 trials), "Coronary Artery Disease" (2 trials), "Peripheral Arterial Disease" (2 trials), "Carotid Artery Stenosis" (1 trials) and "Carotid Stenosis" (1 trials). Many other conditions were trialed in "St. Luke's Medical Center" in a lesser frequency.

Most popular intervention types in "St. Luke's Medical Center" are "Device" (9 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BO-653" (1 trials), "Balloon" (1 trials), "CINCOR™ System and contrast conservation unit (CCS-1)" (1 trials), "CTO Crossing and Percutaneous transluminal angioplasty" (1 trials) and "EverFlex™ Self-Expanding Peripheral Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Medical Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "St. Luke's Medical Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St. Luke's Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".